Ardent Health (NYSE:ARDT) Upgraded at Zacks Research

Zacks Research upgraded shares of Ardent Health (NYSE:ARDT) from a strong sell rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports.

Several other analysts also recently commented on ARDT. Leerink Partners lowered their price objective on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ardent Health in a research report on Monday, December 29th. Mizuho decreased their price target on Ardent Health from $20.00 to $12.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. UBS Group lowered their price target on Ardent Health from $14.50 to $14.00 and set a “buy” rating for the company in a research report on Thursday, December 18th. Finally, JPMorgan Chase & Co. dropped their price objective on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Seven analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $14.25.

Ardent Health Stock Down 2.4%

Shares of NYSE ARDT opened at $8.57 on Wednesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.97 and a quick ratio of 1.85. The company has a 50-day moving average price of $9.00 and a 200-day moving average price of $10.59. The stock has a market capitalization of $1.22 billion, a P/E ratio of 8.93 and a beta of 0.46. Ardent Health has a 1 year low of $8.07 and a 1 year high of $15.48.

Ardent Health (NYSE:ARDT) last posted its earnings results on Wednesday, March 4th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). Ardent Health had a return on equity of 14.30% and a net margin of 2.15%.The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.63 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, equities research analysts forecast that Ardent Health will post 1.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds and other institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Ardent Health by 103.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock valued at $194,000 after acquiring an additional 7,182 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after acquiring an additional 724,841 shares during the period. Jane Street Group LLC boosted its position in Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after purchasing an additional 40,318 shares during the last quarter. Acadian Asset Management LLC boosted its position in Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock worth $550,000 after purchasing an additional 34,276 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Ardent Health by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.